Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial (vol 181, pg 1612, 2021)Alex C. Spyropoulos,Mark Goldin,Dimitrios Giannis,Wassim Diab,Janice Wang,Sameer Khanijo,Andrea Mignatti,Eugenia Gianos,Marc Cohen,Gulru Sharifova,Jeet M. Lund,Alfonso Tafur,Paul A. Lewis,Kevin P. Cohoon,Husneara Rahman,Cristina P. Sison,Martin L. Lesser,Kanta Ochani,Nirav Agrawal,Judith Hsia,Victoria E. Anderson,Marc Bonaca,Jonathan L. Halperin,Jeffrey I. WeitzJAMA INTERNAL MEDICINE(2022)引用 1|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要